AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: Promega Corporation (promega.com)
Promega is a high-substance scientific entity that obscures its technical depth behind a thin layer of standard corporate fluff. While the forensic and bioluminescence data provide extreme substance, the site’s total lack of structured data (schema) and missing regulatory certificate numbers create a 29-point BS gap that is purely administrative.
Add specific ISO 13485 and GMP certification numbers to the Clinical Diagnostics section of the homepage to move from trust theatre to hard proof. Implement Organization and Person schema for the brand and CEO Bill Linton to anchor the 45-year history in structured data. Replace the vague H1 Transforming Science Together with a substance-led headline highlighting the 4,000+ reagent catalog. Add direct outbound links to the peer-reviewed studies supporting the NanoBRET TE system claims.
Information density is generally high, though degraded by fluff-saturated headings like H1 Transforming Science Together and H3 Driving scientific discovery through creativity and connection. However, the body substance ratio is strong, citing specific metrics such as 4,000+ products, 2,200+ employees, and 45 years of history. Technical specificity is found in low-level headings such as H5 NanoBRET TE K192 Kinase Selectivity System and descriptions of GoTaq Probe qPCR systems. The specificity absence score is 0 due to 8+ instances of hard numbers and named technical frameworks across the crawled pages.
Weak or disconnected schema makes your brand invisible in AI driven retrieval. Generate your Structured Data Audit and quantify the trust, visibility, and ranking loss caused by semantic gaps.
Semantic drift is nearly non-existent. The homepage promise of groundbreaking tools and collaboration is directly substantiated by the Support and About Us pages, which detail technical service availability and a historical timeline of product launches like the RNasin RNase Inhibitor. A minor drift is noted between the H1’s vague collaborative tone and the highly transactional nature of the Quick Order and Account sections, but it does not constitute a significant disconnect.
Our Authority as a Service model transforms raw diagnostic data into high stakes results. Start your Clinical Strategic Diagnosis for 1 Euro to secure the strategic fixes required for growth.
The site avoids standard trust theatre; while the About Us page shows a review_count of 3, the proof_links_count of 1 suggests a verified link. However, the site makes bold performance claims such as worldwide leader and stringent QC standards without providing direct links to ISO certificates or regulatory registration numbers (FDA 510(k)) on the primary application pages. Evidence from 2024 regarding the ISHI gathering is aging (24 months from the system date) but remains relevant for industry-standard longevity.
Proof density is high, with a strong ratio of verifiable evidence to vague assertions. Specific proof points include the 1978 founding date, the 100+ countries served, and the specific award won for the NanoBRET TE assay. Vague assertions like high-value products are the exception rather than the rule.
To see how the system reconstructs a medical entity graph at scale, review the full Cleveland Clinic Structured Data audit. View the Cleveland Clinic Structured Data Audit for a live example of identity level decomposition and cross page entity mapping.
The site uses several industry clichés such as science-driven solutions and innovative solutions, which appear in the generic_claims and value_prop_cliches arrays. Despite this, the value proposition is unique to the niche of bioluminescent sensors and forensic DNA (PowerPlex systems), making it difficult to copy-paste onto a generic competitor. Boilerplate sections like Why Choose Us are present but populated with unique historical data, such as 9/11 identification work, which reduces the template language penalty.
Authority gaps are primarily technical; despite naming CEO Bill Linton, the site lacks structured Person schema or sameAs links to verify his digital footprint within the provided data. Furthermore, the schema_json is null across all four pages, representing a major credibility gap for a company claiming technical excellence. There is a lack of explicit manufacturing quality certifications (e.g., ISO 13485) linked directly within the Applications text blocks.
There is a slight disconnect between the high-level marketing tone (Transforming Science Together) and the technical reality of reagent supply. However, the site demonstrates its claims through detailed history (e.g., COVID-19 manufacturing tenfold increase) rather than just stating them. The primary disconnect is the lack of direct citations for claims regarding understudied protein classes in the Customer Spotlight section.
Medical Devices, Pharma & Biotech BS: Promega Corporation (promega.com)
The site content perfectly aligns with the Medical Devices, Pharma & Biotech industry, evidenced by specific references to biochemical reagents, molecular biology, forensic DNA analysis, and clinical diagnostics manufacturing under QC standards.
AI cannot build a coherent graph if the same page resolves into multiple identities. Explore the URL & Canonical Hygiene Technical Framework to understand how identity stability prevents duplicate embeddings and semantic drift.
“The score was primarily driven by the Identity and Authority pillar (10/15) due to the complete absence of schema_json and person-specific sameAs links. Information Density (6/30) and Trust and Proof (6/20) remained low due to the high volume of specific technical nouns and historical milestones that counteracted generic marketing language.”